Search Results - "Dietrich, Christoph G"

Screening for nonalcoholic fatty liver disease-when, who and how? by Dietrich, Christoph G, Rau, Monika, Geier, Andreas

“…Nonalcoholic fatty liver disease (NAFLD) is becoming a frequent liver disease, especially in patients with metabolic syndrome and especially in Western…”
Get full text

Commercially available probiotic drinks containing Lactobacillus casei DN-114001 reduce antibiotic-associated diarrhea by Dietrich, Christoph G, Kottmann, Tanja, Alavi, Manuela

“…AIM:To investigate the effect of Lactobacillus-containing commercially available probiotic formulations in Germany during antibiotic treatment with an analysis…”
Get full text

Non-alcoholic fatty liver disease and COVID-19: Harmless companions or disease intensifier? by Dietrich, Christoph G, Geier, Andreas, Merle, Uta

“…The pandemics of coronavirus disease 2019 (COVID-19) and non-alcoholic fatty liver disease (NAFLD) coexist. Elevated liver function tests are frequent in…”
Get full text

Percutaneous endoscopic gastrostomy - Too often? Too late? Who are the right patients for gastrostomy? by Dietrich, Christoph G, Schoppmeyer, Konrad

“…Percutaneous endoscopic gastrostomy is an established method to provide nutrition to patients with restricted oral uptake of fluids and calories. Here, we…”
Get full text

Downregulation of breast cancer resistance protein in colon adenomas reduces cellular xenobiotic resistance and leads to accumulation of a food‐derived carcinogen by Dietrich, Christoph G., Vehr, Ann‐Kathrin, Martin, Ina V., Gaßler, Nikolaus, Rath, Timo, Roeb, Elke, Schmitt, Johannes, Trautwein, Christian, Geier, Andreas

“…Several molecular changes in colorectal adenomas provide the basis of the adenoma–carcinoma sequence. We investigated the expression of xenobiotic ATP‐binding…”
Get full text

Opportunities and risks of advance directives : An appraisal of the practice in Germany after legal regulation in 2009 by Dietrich, Christoph G, Schoppmeyer, Konrad

“…Living wills/advance directives (AD) are an important tool for specifying patient wishes regarding medical care in the case of future inability to consent…”
Get full text

Cytokine-dependent regulation of hepatic organic anion transporter gene transactivators in mouse liver by Geier, Andreas, Dietrich, Christoph G, Voigt, Sebastian, Ananthanarayanan, Meenakshisundaram, Lammert, Frank, Schmitz, Anne, Trauner, Michael, Wasmuth, Hermann E, Boraschi, Diana, Balasubramaniyan, Natarajan, Suchy, Frederick J, Matern, Siegfried, Gartung, Carsten

“…Proinflammatory cytokines such as TNF-alpha and IL-1beta lead to downregulation of hepatic organic anion transporters in cholestasis. This adapted response is…”
Get more information

Percutaneous gastrostomy – Too often? Too late? Who are the right patients for gastrostomy? by Dietrich, Christoph G, Schoppmeyer, Konrad

Get full text

Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration by Geier, Andreas, Wagner, Martin, Dietrich, Christoph G., Trauner, Michael

“…Hepatic uptake and biliary excretion of organic anions (e.g., bile acids and bilirubin) is mediated by hepatobiliary transport systems. Defects in transporter…”
Get full text

Primary presentation of COVID-19 solely with gastrointestinal symptoms: a problem for the containment of the disease by Dietrich, Christoph G., Hübner, Dolores, Marx, Gernot, Bickenbach, Johannes, Bootsveld, Andreas

“…An oligosymptomatic patient with initially exclusively gastrointestinal symptoms (massive nausea and mild pancreatitis) turned out to suffer from COVID-19…”
Get full text

Intake of Acetylsalicylic Acid and High Age Are Risk Factors for Iron Deficiency Anemia in Patients with Large Diaphragmatic Hernias by Dietrich, Christoph G, Kottmann, Tanja, Holtdirk, Annette, Heise, Joachim W

“…In 15% of patients with iron deficiency anemia, large diaphragmatic hernias are found as the cause of chronic iron loss. Conversely, iron deficiency anemia is…”
Get more information

Molecular changes in hepatic metabolism and transport in cirrhosis and their functional importance by Dietrich, Christoph G, Götze, Oliver, Geier, Andreas

“…Liver cirrhosis is the common endpoint of many hepatic diseases and represents a relevant risk for liver failure and hepatocellular carcinoma. The progress of…”
Get full text

Consequences of bile duct obstruction on intestinal expression and function of multidrug resistance-associated protein 2 by Dietrich, Christoph G., Geier, Andreas, Salein, Nina, Lammert, Frank, Roeb, Elke, Oude Elferink, Ronald P.J., Matern, Siegfried, Gartung, Carsten

“…Background & aims: Multidrug resistance-associated protein 2 (MRP2), a transporter of organic anions in hepatocytes, renal epithelial cells, and enterocytes,…”
Get full text

Characterization of organic anion transporter regulation, glutathione metabolism and bile formation in the obese Zucker rat by Geier, Andreas, Dietrich, Christoph G., Grote, Tobias, Beuers, Ulrich, Prüfer, Thomas, Fraunberger, Peter, Matern, Siegfried, Gartung, Carsten, Gerbes, Alexander L., Bilzer, Manfred

“…Alterations in hepatobiliary transporters may render fatty livers more vulnerable against various toxic insults. We therefore studied expression and function…”
Get full text

Cytokine blockade inhibits hepatic tissue inhibitor of metalloproteinase-1 expression and up-regulates matrix metalloproteinase-9 in toxic liver injury by Roderfeld, Martin, Geier, Andreas, Dietrich, Christoph G., Siewert, Elmar, Jansen, Bettina, Gartung, Carsten, Roeb, Elke

“…: Background: Tissue inhibitor of metalloproteinases (TIMP)‐1, the most important endogenous inhibitor of matrix metalloproteinases, plays a pivotal role in…”
Get full text

Aloe Vera-Containing Matrix in Transdermal Fentanyl Therapy Improves Adhesion, Skin Tolerance and Quality of Life: Results of a German Multicenter Study with a New Fentanyl Patch by Dietrich, Christoph G, Kottmann, Tanja, Voß, Hans Werner, Lorenz, Roxane

“…Chronic pain represents a significant and costly healthcare problem especially in the older patient. Transdermal opioid therapy is easy to apply and ensures…”
Get more information

Changes in drug transport and metabolism and their clinical implications in non-alcoholic fatty liver disease by Dietrich, Christoph G, Rau, Monika, Jahn, Daniel, Geier, Andreas

“…The incidence of non-alcoholic fatty liver disease (NAFLD) is rising, especially in Western countries. Drug treatment in patients with NAFLD is common since it…”
Get more information

Hepatobiliary organic anion transporters are differentially regulated in acute toxic liver injury induced by carbon tetrachloride by Geier, Andreas, Kim, Suk Kyum, Gerloff, Thomas, Dietrich, Christoph G, Lammert, Frank, Karpen, Saul J, Stieger, Bruno, Meier, Peter J, Matern, Siegfried, Gartung, Carsten

“…Background/Aims : Hepatobiliary transporters are down-regulated in cholestasis, but their expression in acute, non-cholestatic, cytokine-mediated liver injury…”
Get full text

Origin of and therapeutic approach to cardiac syndrome X: results of the proton pump inhibitor therapy for angina-like lingering pain trial (PITFALL trial) by Dietrich, Christoph-G, Laupichler, Susanne, Stanzel, Sven, Winograd, Ron, Al-Taie, Oliver, Gartung, Carsten, Geier, Andreas

“…To investigate the frequency of gastroenterological diseases in the etiology and the efficacy of proton pump inhibitors (PPIs) in the treatment of cardiac…”
Get full text

Effect of drug transporter pharmacogenetics on cholestasis by Dietrich, Christoph G, Geier, Andreas

“…The liver is the central place for the metabolism of drugs and other xenobiotics. In the liver cell, oxidation and conjugation of compounds take place, and at…”
Get more information